In the early 2000s the U.S. Diabetes Prevention Program (DPP), a large randomized clinical trial, showed that intensive lifestyle modification was ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...

Cardiovascular disease is the leading cause of morbidity and mortality in patients with end-stage kidney disease. Currently, thrice-weekly in-center hemodialysis for 3 to 5 hours per session is the ...